
How analytics-driven insights can help drugmakers navigate the leap from trial to market—and add clinical and financial value at every step

How analytics-driven insights can help drugmakers navigate the leap from trial to market—and add clinical and financial value at every step

A conversation with Jane Quigley, senior VP, Digital Health, PRA Health Sciences

Embracing AI 2.0 and modern machine learning as foundational tools to deepening HCP engagement


Using technology to enable processes, drive cost savings, and deliver better patient outcomes

Are regulations hindering pharma innovations?

Go-to safeguards for manufacturers in avoiding mismanagement of their business-central records

Building in the right processes and support for data quality, standards, and governance

With their role in logistics chain, association believes that aviation workers should be given higher priority

Carlsbad structure will house material for cell and gene-based therapies

As it awaits status of Moderna vaccine, Swedish CDMO receives tender

Can meet temperatures needed for doses of Pfizer, Moderna and AstraZeneca vaccines

A one-on-one with Fabian Gerlinghaus, co-founder and CEO of Cellares, who discusses the quest to overcome bottlenecks in industrial scale cell therapy manufacturing

Thermal packager provided temperature-sensitive resources

At best, 25 million doses might be available by year-end, sufficient for half that many Americans

Report on member-distributor performance metrics for 2019

German company a new member of fledgling RFID-tech association DoseID

Kit Check platform provides structure to sort hospital inventory

Decision a win for independent pharmacies in claim of PBM abuse of power

SeaCube acquisition adds technology to its container fleet

Launches platform to expand access via value-based contracting arrangements

October trends point to rising demand but at a slower pace

Infusion expected to double CPO’s packaging capacity

Five ways to adapt manufacturer-sponsored programs

Rising prevalence of infectious diseases to be key driver

Joint effort provides a time-efficient transport option

Goal is to enable support of partners through its expertise and resources

Illustrates that majority of pharma sales were made through organization’s traditional distributor network

Partners with ArisGlobal to improve the patient support and pharmacovigilance experience